CDA Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries

Description

Project Purpose Statement The purpose of this project is to create a new HL7 IG based on the existing CDC IG for Ambulatory Healthcare Provider Reporting to Central Cancer Registries and update it to: align with C-CDA; add new identified data elements, vocabularies, and other requirements; update/clarify conformance statements; and other changes that may be identified. The IG will define a new 'Ambulatory Healthcare Provider Cancer Event Report' document-level template, which would leverage a new section-level template for 'Cancer Diagnosis';. IG Scope and Background This IG facilitates the development of systems that allow for automated transmission of patient-centric cancer case data from ambulatory healthcare providers' EHRs to public health central cancer registries. It contains the specifications for identifying reportable cancers, describes the standard HL7 CDA R2 format and structure of the data elements to be retrieved from the EHR to produce the cancer event report, and indicates when a cancer event report must be transmitted. Methods for public health central cancer registries to process cancer event reports from ambulatory healthcare providers and transport mechanisms between EHRs and public health central cancer registries are NOT included in the scope of this IG.

Co-Chair Sponsor: Laura Rappleye

Last Reviewed: 2/1/18

Misc Notes
2026 January: TSC approved an STU Extension Request for HL7 CDA ® Release 2 Implementation Guide: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1, DSTU Release 1.1 – US Realm 2023 December: TSC approved STU Extension Request for HL7 CDA R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm 2021 Dec: TSC approved STU extension request for HL7 CDA R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm for 2 years. 2021 Sept: TSC approve STU publication request for HL7 CDA R2 Implementation Guide: Ambulatory and Hospital Healthcare Provider Reporting to Birth Defect Registries Release 1 STU 2.1 - US Realm 2019 March: TSC approved STU Extension Request ?by the Public Health WG of the Clinical SD for HL7 CDA® R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm through March 5, 2020 2018 March: TSC approved STU Extension Request for HL7 CDA® R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm at TSC Tracker 14352 for 1 year. 2016: TSC approved STU Extension Request for HL7 CDA® R2 IG: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, R1, DSTU Release 1.1 - US Realm at TSC Tracker 12458 through 2018-01-20. HL7 Implementation Guide for CDA® Release 2: Reporting to Public Health Cancer Registries from Ambulatory Healthcare Providers, Release 1 - US Realm in DSTU through December 17, 2016 July 2014: J Roberts: added Mark Roche as a Modeling Facilitator; included Clinical Genomics as an interested party, at their request. section 5 intent; supplement to current standard: Revising the US CDA standard (CDA R2 C-CDA-R1.1)